FOLD - Amicus Therapeutics' (FOLD) CEO John Crowley on Q4 2020 Results - Earnings Call Transcript

Amicus Therapeutics, Inc. (FOLD) Q4 2020 Earnings Conference Call March 1, 2021, 8:30 am ET Company Participants Andrew Faughnan - Head, IR John Crowley - Chairman & CEO Bradley Campbell - President & COO Jeff Castelli - CDO Daphne Quimi - CFO Hung Do - Chief Science Officer Mitchell Goldman - SVP, Clinical Research Conference Call Participants Tazeen Ahmad - Bank of America Irina Margine - Cowen Tessa Romero - JP Morgan Mohit Bansal - Citigroup Kristen Kluska - Cantor Fitzgerald Aaron Welch - Guggenheim Securities Presentation Operator Good morning, ladies and gentlemen, and welcome to the Amicus Therapeutics Fourth Quarter 2020 Fiscal Year Results Conference Call and Webcast. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions]. As a reminder, this conference is being recorded. I would now like to turn the conference

For further details see:

Amicus Therapeutics' (FOLD) CEO John Crowley on Q4 2020 Results - Earnings Call Transcript